These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30534046)

  • 1. Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease.
    Sun Y; Pham AN; Hare DJ; Waite TD
    Front Neurosci; 2018; 12():859. PubMed ID: 30534046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and toxic roles of dopamine in Parkinson's disease.
    Segura-Aguilar J; Paris I; Muñoz P; Ferrari E; Zecca L; Zucca FA
    J Neurochem; 2014 Jun; 129(6):898-915. PubMed ID: 24548101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.
    Sun Y; Pham AN; Waite TD
    J Neurochem; 2016 Jun; 137(6):955-68. PubMed ID: 26991725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson's Disease.
    Sun Y; Pham AN; Hider RC; Zheng H; Waite TD
    ACS Chem Neurosci; 2020 Nov; 11(21):3646-3657. PubMed ID: 33143428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease.
    Pezzella A; d'Ischia M; Napolitano A; Misuraca G; Prota G
    J Med Chem; 1997 Jul; 40(14):2211-6. PubMed ID: 9216840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
    J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.
    Zafar KS; Siegel D; Ross D
    Mol Pharmacol; 2006 Sep; 70(3):1079-86. PubMed ID: 16790533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of vitamin C and iron on dopamine-mediated free radical generation: implications to Parkinson's disease.
    Sun Y; Pham AN; Waite TD
    Dalton Trans; 2018 Mar; 47(12):4059-4069. PubMed ID: 29406547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1.
    Aguirre P; Urrutia P; Tapia V; Villa M; Paris I; Segura-Aguilar J; Núñez MT
    Biometals; 2012 Aug; 25(4):795-803. PubMed ID: 22302610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron paramagnetic resonance study of the generation of reactive oxygen species catalysed by transition metals and quinoid redox cycling by inhalable ambient particulate matter.
    Valavanidis A; Fiotakis K; Bakeas E; Vlahogianni T
    Redox Rep; 2005; 10(1):37-51. PubMed ID: 15829110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.
    Hermida-Ameijeiras A; Méndez-Alvarez E; Sánchez-Iglesias S; Sanmartín-Suárez C; Soto-Otero R
    Neurochem Int; 2004 Jul; 45(1):103-16. PubMed ID: 15082228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of ferric iron links oxidative stress to α-synuclein oligomer formation.
    Levin J; Högen T; Hillmer AS; Bader B; Schmidt F; Kamp F; Kretzschmar HA; Bötzel K; Giese A
    J Parkinsons Dis; 2011; 1(2):205-16. PubMed ID: 23934922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system.
    Segura-Aguilar J; Metodiewa D; Baez S
    Neurotox Res; 2001 Apr; 3(2):157-65. PubMed ID: 14715470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of release of dopamine on iron transformations and reactive oxygen species (ROS) generation under conditions typical of coastal waters.
    Sun Y; Pham AN; Waite TD
    Environ Sci Process Impacts; 2018 Jan; 20(1):232-244. PubMed ID: 29265130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction.
    Pláteník J; Stopka P; Vejrazka M; Stípek S
    Free Radic Res; 2001 May; 34(5):445-59. PubMed ID: 11378528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroquinone-Mediated Redox Cycling of Iron and Concomitant Oxidation of Hydroquinone in Oxic Waters under Acidic Conditions: Comparison with Iron-Natural Organic Matter Interactions.
    Jiang C; Garg S; Waite TD
    Environ Sci Technol; 2015 Dec; 49(24):14076-84. PubMed ID: 26579728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.
    Paris I; Martinez-Alvarado P; Cárdenas S; Perez-Pastene C; Graumann R; Fuentes P; Olea-Azar C; Caviedes P; Segura-Aguilar J
    Chem Res Toxicol; 2005 Mar; 18(3):415-9. PubMed ID: 15777081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L; Casella L; Albertini A; Bellei C; Zucca FA; Engelen M; Zadlo A; Szewczyk G; Zareba M; Sarna T
    J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
    Andersen JK
    Novartis Found Symp; 2001; 235():11-20; discussion 20-5. PubMed ID: 11280021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease].
    Bertrand E; Lechowicz W; Szpak GM; Dymecki J
    Neurol Neurochir Pol; 1997; 31(2):295-302. PubMed ID: 9380259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.